Comment on

• Increased risk of incident dementia following use of anticholinergic agents: A systematic literature review and meta-analysis.

  Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, Girman C, Radican L, Mudd PN Jr, Poole C. Dmochowski RR, et al. Neurourol Urodyn. 2021 Jan;40(1):28-37. doi: 10.1002/nau.24536. Epub 2020 Oct 23. Neurourol Urodyn. 2021. PMID: 33098213 Free PMC article.
• Low-intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta-analysis.

  Mykoniatis I, Pyrgidis N, Sokolakis I, Sountoulides P, Hatzichristodoulou G, Apostolidis A, Hatzichristou D. Mykoniatis I, et al. BJU Int. 2021 Aug;128(2):144-152. doi: 10.1111/bju.15335. Epub 2021 Mar 3. BJU Int. 2021. PMID: 33434323
• Cluster analysis of men undergoing surgery for BPH/LUTS reveals prominent roles of both bladder outlet obstruction and diminished bladder contractility.

  Schneider AJ, Grimes M, Lyon W, Kemper A, Wang S, Bushman W. Schneider AJ, et al. PLoS One. 2021 May 24;16(5):e0251721. doi: 10.1371/journal.pone.0251721. eCollection 2021. PLoS One. 2021. PMID: 34029333 Free PMC article.
• Cardiovascular safety of vibegron, a new β3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study.

  Yoshida M, Takeda M, Gotoh M, Yokoyama O, Kakizaki H, Takahashi S, Masumori N, Nagai S, Minemura K. Yoshida M, et al. Neurourol Urodyn. 2021 Aug;40(6):1651-1660. doi: 10.1002/nau.24732. Epub 2021 Jun 17. Neurourol Urodyn. 2021. PMID: 34139038 Free PMC article. Clinical Trial.